The provided excel file provides additional information not displayed in Figure 1 of the main text.
Of the variants now designated NUDT*1 through *19, six have been published using star nomenclature (*1-*6, *10 and *11) (1) (2) (3) ; PMID numbers are shown in column AA and are fully referenced below). Haplotypes designated *7-*9 were named as such post-hoc. Six novel haplotypes designated *14-*19 represent recent submissions to PharmVar (submitting author is provided in column AB. Some haplotypes are based on direct submissions only, i.e. have not been formally published elsewhere.
Per PharmVar allele designation criteria (available through the SUBMISSIONS menu tab on www.PharmVar.org), haplotypes carrying a synonymous SNV and/or a SNV in noncoding regions and are not known to impact function are designated as suballeles. Consequently, five variants have been designated as NUDT15*1 suballeles.
PharmVar is implementing an updated haplotype versioning system that allows tracking of suballeles. As described (4), each haplotype now receives a numeric extension, signifying that e.g. NUDT15*1.005 is a subvariant of NUDT15*1. All variants listed under the same star (*) number are deemed to have the same or comparable function. To date, no suballeles have been identified for NUDT15*2 through *19.
The figure provides information regarding allele function based on in-vitro activity towards two substrates, TGTP and TdTP (2, 3, 5). Reduced thermostability has been shown to be an indicator of enzyme function and is also provided, if available. For some allelic variants there is no or very limited information and therefore, it remains unknown whether these alleles cause toxicity in-vivo. For NUDT*2 and *3 a clear association with 6MP intolerance has been reported but not for others. "Yes' in column AE indicates that some clinical data exist supporting that an allele contributes to toxicity regardless of the strength of evidence. Note that a number of allelic variants are categorized by PharmVar as 'severely decreased function' based on in-vitro activity while CPIC categorized these alleles as 'no function' in their guideline (6) . No function assignments have been made by CPIC for NUDT*10-*19 (tbd, to be determined). This information is also available in the READ ME document posted on the PharmVar gene page and the PharmGKB where updated information will be available.
